Upload
halien
View
212
Download
0
Embed Size (px)
Citation preview
Functional Genomics: using genome-wide approaches to unveil gene
function
1st bacteria
1st arqueobacteriaHaemophilus influenza
The post-genomic era
Mammals
Insects
Mus musculus
Anopheles gambiae
Homo sapiens Canis familiaris
1st eukaryote
1st eukaryoteMethanococcus janaschii
Saccharomyces cerevisiae
Plants
Drosophila melanogaster
Arabidopsis thaliana
Gallus gallus
Oryza sativa
Pan troglodytes
Birds
Fugu rubripes
Fish
Saccharomyces cerevisiae
Functional analysis in the post-genomic world
YBR180w
YIL120w
YIL121w
YBR043c
YNL065w
Cluster I
A WHOLE NEW WORLD…OF REVERSE GENETICS
YNR055c
YPR156c
YGR138c
YOR273c
YOR273c
YHR048w
YBR008c
Cluster II
A WHOLE NEW WORLD…OF REVERSE GENETICS
Characterization of the participation of the new MDR transporters in resistance to multiple drugs and chemical stresses
Systematic functional analysis of yeast multidrug resistance transporters
b)a) c) b)a) c)
wt
∆∆∆∆geneA
∆∆∆∆genA∆∆∆∆genB
∆∆∆∆geneB
b)a) c) b)a) c)
Protein sub-celular localization
Systematic functional analysis of yeast multidrug resistance transporters
Proteina de fusão ORF-GFP
Transport assays to determine the role of each MDR transporters in drug extrusion
Systematic functional analysis of yeast multidrug resistance transporters
Studies on the stress induced changes at the transcript and protein levels, by Northern blotting, RT-PCR and Western blotting
Acti
vati
on
fo
ld
Gene1
5
10
15
Gene2
5 2.5 5 7 140
Strain:
Time (h):
wt∆∆∆∆geneA
ProteinA
Pma1p
B
Systematic functional analysis of yeast multidrug resistance transporters
Strain
Acti
vati
on
fo
ld
Gene3 Gene4
5
0
5
10
0
0.2
0.4
0.6
0.8
Pro
tein
A/P
ma1
p (�
)
(arb
itra
ry u
nits
)Time (h)
0 10 20 300.1
1
10
(�)
Characterization of the physiological role of new MDR transporters
DTR1 (YBR180w)QuinineQuinidinePropionic acidBarban
QDR1 (YIL120w)QuinidineFluconazoleKetoconazoleBarban
QDR2 (YIL121w)QuinidineKetoconazoleBarbanCisplatinBleomycin
QDR3 (YBR043c)QuinidineKetoconazoleFluconazoleBarbanCisplatin
AQR1 (YNL065w)QuinineQuinidineKetoconazoleBarban
Crystal violetAcetic acidPropionic acidButyric acid
Cluster I
Systematic functional analysis of yeast multidrug resistance transporters
NystatinMCPA2,4-DArtesunateMycophenolic acidCaspofunginIndomethacin
CisplatinBleomycinMn2+
HOL1 (YNR055c)Histidinol uptake
TPO3 (YPR156c)Polyamine
- SpermineQuinidineAcetic acidPropionic acidButyric acid
TPO2 (YGR138c)Polyamine
- SpermineQuinidineAcetic acidPropionic acidButyric acid
TPO4 (YoR273c)Polyamine
- SpermineQuinidineCycloheximide
TPO1 (YoR273c)Polyamine
- Spermine- Putrescine- Spermidine
QuinidineCycloheximide
YHK8 (YHR048w)ItraconazoleFluconazole
FLR1 (YBR008c)FluconazoleCycloheximide4-NQOMancozebBenomylMethotrexate
DiazoborineCeruleninDiamideDiethylmaleateMenadioneParacetamol
Cluster II
Functional Genomics
- a field of molecular biology that attempts to make use of the
vast wealth of data produced by genomic projects to describe
gene functions and interactions, foccusing on the dynamic
aspects of gene transcription, translation, interactions...
EUROPEAN SCIENCE FOUNDATION PROGRAMME ON
FRONTIERS OF FUNCTIONAL GENOMICS
Functional Genomics
“New” experimental methods to obtain genome-wide data
Phenotypic analysis:• disruptome• genetic interactions
Gene expression analysis:• at the RNA level• at the protein level• at the protein level
Physical and chemical interactions within the cell• protein-protein• protein-DNA• protein-lipids/substracts• protein modifications
Metabolome and fluxome analysis
Integrative approaches – Systems Biology
Methods for genome-wide phenotypic analysis
Disruptome analysis
Control Stress
Chemical genomic portrait of Yeast
Chemical genomic portrait of Yeast
Chemical genomic portrait of Yeast
Methods for genome-wide phenotypic analysis
Disruptome analysis: competition assays
Each deletion mutant contains specific Tags
kanMX4
kanMX4
PCR
Tag 1Tag 2
Methods for genome-wide phenotypic analysis
Disruptome analysis: competition assays
Relative quantification of the
abundance of each unique tag
KAN RTAG
TAG
TAGTAG
TAG
TAG
Array de Tags
Methods for genome-wide phenotypic analysis
Synthetic lethality – SGA method
Methods for genome-wide phenotypic analysis
Synthetic lethality – SGA method
132 SGAs permitem
estabelecer cerca de
4000 interacções entre
cerca de 1000 genes de
levedura
Methods for genome-wide phenotypic analysis
Synthetic lethality – SGA method
Methods for genome-wide phenotypic analysis
Synthetic lethality – SGA method
Genome-wide expression analysis: transcriptomics
DNA MicroarraysMeasures the concentration of each transcript in the cell, including mRNA, rRNA, tRNA, sRNA.
Control Stress
Genome-wide expression analysis: proteomics
Electroforése bidimensional
• mede-se a concentração de cada proteína/forma proteíca na célula.
6.05.04.5
MW/kDa
pI
97.0
66.0
45.0
control + stress
His4p
Met6p
30.0
20.1
14.4
Hsp12p
Ahp1p(oxidized form)
Ahp1p(reduced form)
LOCALIZOMICSSub-celullar protein localization at the proteome-wide scale
Huh et al., Nature,
2003, 425: 686-91
75% of the proteome in natural conditions
Flow cytometry analysis of candidate deletion strains.
Plot of the log10 fluorescence of candidate deletion
strains tested at 6 h and 24 h of oleate incubation.
Deletion strains are indicated with open circles, while
wild type is indicated by the line. The tables at the right
show the flow cytometry analysis of the candidate genes
with percentage of Pot1p-GFP fluorescence relative to
wild type, the mean of the fluorescence values and the z
value or standard score of the fluorescence at 6 h or 24 h
respectively. Genes are shown that show decreases of
Pot1p-GFP fluorescence that are at least 1SD from the
wild type POT1-GFP strain. Genes boxed by blue or red
indicate the naturally occurring separation of values
shown in the plot at 6 h (blue) and 24 h (red).
Identification of
peroxisomal mutants.
Bright field images are
shown on the left panel and
fluorescence images are
shown on the right. Known
peroxins show
mislocalization of themislocalization of the
Pot1p-GFP reporter when
deleted. Partial
mislocalization phenotypes
are seen in pex1D, pex18D,
and pex21D.
Vps52p, Pir3p and YKL015C are novel peroxisome
inheritance factors. A. Strains lacking Inp1p, Vps52p, Pir3p
or YKL015Cp accumulate peroxisomes near the bud neck or
in daughter cells as indicated by the arrowheads. B.
Summary of the effect of (i) deletions, (ii) complementation,
and (iii) double deletions of vps52D, pir3D and ykl015cD.
Mnn11p and Hsl7p are regulators of
peroxisome morphology. Strains deleted for
mnn11 or the 59 end of hsl7 (hsl7DN generated
by the ybr134w deletion) were backcrossed
against an allelic deletion or a wild type strain
(BY4742). An increased number of small
peroxisomes are seen in cells deleted for
mnn11, while hsl7DN lead to an increase in
size or tendency for the peroxisomes to cluster.
Both phenotypes are complemented by mating
to the wild type strain.
Single-cell quantification of GFP-tagged protein levels reveals diverse proteomic changes during nitrogen starvation.
Breker M et al. J Cell Biol 2013;200:839-850
© 2013 Breker et al.
A bet-hedging strategy in yeast underlies prolonged survival under starvation.
Breker M et al. J Cell Biol 2013;200:839-850
© 2013 Breker et al.
Integration of proteome abundance and subcellular organization enables characterization of the dynamics of organelle morphology and composition under stress.
Breker M et al. J Cell Biol 2013;200:839-850
© 2013 Breker et al.
Protein localization is dynamic under stress.
Breker M et al. J Cell Biol 2013;200:839-850
© 2013 Breker et al.
Integration of all proteomic changes gives a “thumbprint” of cellular stress responses.
Breker M et al. J Cell Biol 2013;200:839-850
© 2013 Breker et al.
“New” experimental methods to obtain genome-wide data
Phenotypic analysis:• disruptome• genetic interactions
Gene expression analysis:• at the RNA level• at the protein level
Physical and chemical interactions within the cellPhysical and chemical interactions within the cell• protein-protein• protein-DNA• protein-lipids/substracts• protein modifications
Metabolome and fluxome analysis
Integrative approaches – Systems Biology
BaitProtein
BindingDomain
Prey Protein
ActivationDomain
Protein-protein interaction analysis : two-hybrid system
For cytosolic proteins: classical Gal4 method
Reporter GeneDomain
Reporter Gene
BaitProtein
BindingDomain
Prey Protein
ActivationDomain
Protein-protein interaction analysis : two-hybrid system
For membrane protein: split-ubiquitin method
Protein-protein interaction analysis : fluorescence complementation
In vivo detection of protein-protein interaction in their sub-cellular localization
Protein-protein interaction analysis : fluorescence complementation
INTERACTÓMICAAnálise de interacções proteicas: método de dois híbridos
à escala do genoma
Análise de interacções proteicas: método de dois híbridosà escala do genoma - resultados
Neste único trabalho:
4549 interacções (de entre 4 milhões testadas).
Science, 2001, 293: 2101-2105
Análise de interacções proteicas: chips de proteínas
Detecção de interacções proteicas in vitro na sua localização subcelular
Análise de interacções proteicas: chips de proteínas
Protein-ligand interaction analysis:
protein chips
Análise de interacções proteína-DNA: ChIP e ChIP-on-chip
Crosslink DNA in vivo
Fragmentação do DNA
ChIP
Isolamento do complexo proteína-DNA por imunoprecipitação
Amplificação por PCR de fragmentos específicos
Análise de interacções proteína-DNA: ChIP e ChIP-on-chip
Isolamento de todos os complexos proteína-DNA por imunoprecipitação
ChIP-on-chip
Hibridação em microarrays de promotores de todos os fragmentos de DNA
Análise de interacções proteína-DNA: ChIP-on-chip
Expression proteomics using antibody chips
Chemical chips
Chemical chip is a platform were chemical
interactions may performed, registered and
analyzed.
DNA, protein and antibodies chips are specific
(bio)chemical chips.(bio)chemical chips.
With nanotechnologies high-throughput analysis,
reduced sample volumes, integration of different
components – Lab-on-a-chip and µTAS (Micro
total analysis system).
Types of chemical chips
Haishing Ma
et al, 2006
Types of chemical chipsDry chemical microarray enzyme assay
The figure report a study of kinase inhibitors:
� 8640 different compounds were spotted in and dried in a polystyrene sheet;
� Agarose gel containing kinase was laid on top of the compounds;
� A second agarose gel containing peptide substrates was laid on top of previous
agarose gel.
Structural proteomics
• Major objective: to obtain experimentally the
3D structures of all the proteins
� Reasonable objective: To determine the structure and obtainrepresentative models of all possible protein folding structures
Structural proteomics
� Goal: Infer the function of new proteins
The most common method is to compare the amino acid
sequence of the new protein with those available for
functional inference functional inference
The 3D structure of a protein is much more conserved than
the primary aminoacid structure!
Structural proteomics
Structural proteomics• Worldwide consortia:
– Protein Structure Initiative (PSI)
– Structural Proteomics in Europe (SPINE)
– National Project on Protein Structural andFunctional Analyses (RIKEN)
� Protein Data Bank (PDB)
•Choosing the protein(s)
•High-throughput expression and purification
Experimental approach
•High-throughput expression and purification
•3D structure determination•X-ray crystallography
•Nuclear magnetic resonance (NMR)
•PDB annotation
TM0449 Protein from Thermotoga maritima: "Thymidylate synthase”
� X-ray crystalography
Examples
New Folding
� New folding identification
� A new pathway for the synthesis
of Thymine in human pathogens
� New target for antibiotics
• MTH1880 from Methanobacterium thermoautotrophicum
– Protein with no sequence homology.
– Structure determination identified an acidic cation bound motif,
leading to the association of Ca-transport to MTH1880 function
Examples
Function prediction from a 3D structure
leading to the association of Ca-transport to MTH1880 function
– Functional prediction to a whole family of uncharacterized proteins
Applications of Functional Genomics
Biomedical:
- Epigenomics
- Neurogenomics and disease
- Pharmacogenomics
- Predictive, preventive and personalized medicine- Predictive, preventive and personalized medicine
Environmental:
- Metagenomics
- Toxicogenomics
Agricultural, Biotechnological, Economical, Social...
Research
SmallMolecules
Animal Models
FunctionalGenomics
Proteomics
CellAssays
DrugTargets
GenesDrugTests
GenomicsCombinatorial Combinatorial
ChemistryChemistryScreening
DrugLeads
Pharmacogenomics
HumanTrials Drug
DevelopmentStage
ApprovalDrug Discovery Preclinical
I II III IV
Clinical
PostPost--genomic approaches in genomic approaches in
Drug Discovery/Development ProcessDrug Discovery/Development Process
Technology
ResearchArea
Bioinformatics
Positional Cloning
Parallel Sequencing
2-D Gel,Mass Spec.
Cellular AssaysModel Organism,Gene Knock-outs
ModelsGenomicsProteomicsGenomics
ChemistryChemistryScreening Pharmacogenomics
Genotyping,Phenotyping,SNPs Markers
StructuralDrug Design
Molecular Informatics
Differential Display, Expression Patterns, Reporter Gene Technologies
Chip Technologies, DNA Chips, Protein Chips, Microarrays
Source: IBM Life Science, 2002
Análise quantitativa de metabolitos
Métodos tradicionais: HPLC, GC, CE, MS
Métodos globais: NMR, MS• conseguem medir de uma só vez dezenas de metabolitos• NMR é quantitativo mas mais limitado no nº de metabolitos que analisa
Análise do metaboloma: 2 caminhos
1234567ppm
Métodos Métodos
1234567ppm
hippurate urea
allantoin creatininehippurate
2-oxoglutarate
citrate
TMAO
succinatefumarate
water
creatinine
taurine
-25
-20
-15
-10
-5
0
5
10
15
20
25
-30 -20 -10 0 10
PC1
PC2
PAP
ANIT
Control
Métodos quantitativos quimiométricos
Ace
tic
Aci
d
Bet
ain
e
Car
nit
ine
Cit
ric
Aci
d
Cre
atin
ine
Dim
eth
ylg
lyci
ne
Dim
eth
yla
min
e
Hip
pu
lric
Aci
d
Lac
tic
Aci
d
Su
ccin
ic A
cid
Tri
met
hyla
min
e
Tri
mn
-N-O
xid
e
Ure
a
Lac
tose
Su
ber
ic A
cid
Seb
acic
Aci
d
Ho
mo
van
illi
c A
cid
Th
reo
nin
e
Ala
nin
e
Gly
cin
e
Glu
cose
Patient 1
Patient 2
Patient 3
Patient 4
Normal
Below Normal
Above Norrmal
Absent
Aplicações clínicas…
Patient 4
Patient 5
Patient 6
Patient 7
Patient 8
Patient 9
Patient 10
Patient 11
Patient 12
Patient 13
Patient 14
Patient 15